Option Bulls Count On a Recovery for MakeMyTrip Limited (MMYT)

MakeMyTrip Limited (MMYT) is having its worst day in over four years

by Alex Eppstein

Published on Jul 30, 2015 at 3:13 PM

MakeMyTrip Limited (NASDAQ:MMYT) is staring at its worst session in more than four years, down 18.3% at $15.81. Earlier, the online travel stock landed on the short-sale restricted list, and also touched an annual low of $15. However, that hasn't stopped option traders from betting on a bounce.

At last check, MMYT calls are crossing at nine times the usual afternoon rate. Looking more closely, buy-to-open activity is transpiring at the in-the-money August 15 strike. Based on the volume-weighted average price (VWAP) of $1.26, these speculators anticipate the stock will muscle back atop breakeven at $16.26 (strike plus VWAP) by the close on Friday, Aug. 21, when front-month options expire.

Today's preference for long calls represents a break from the norm. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), MMYT's 50-day put/call volume ratio rests at an annual peak of 1.85 -- with long puts nearly doubling calls. Likewise, the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.86 registers in the 94th percentile of its 12-month range, suggesting a stronger-than-usual preference for short-term puts over calls.

Option bears are probably happy with MakeMyTrip Limited's (NASDAQ:MMYT) collapse, which was sparked by an earnings miss. Looking back, this makes three consecutive quarterly reports that have sent the equity sharply lower in the ensuing session. In May, MMYT suffered a 13.6% single-day post-earnings loss, and in January, it tumbled 9.6%.

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Wall Street Roars Higher Amid Civil Unrest
Investors weighed a mixed bag of jobs data
AstraZeneca Stock Flat Despite COVID-19 Vaccine News
AstraZeneca saw a rise in capacity for its COVID-19 vaccine candidate
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.